← All trials
NCT05210413
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2022
- Primary completion
- Oct 1, 2026
- Completion date
- Oct 1, 2027
- First posted
- Jan 27, 2022
- Last posted
- Mar 25, 2022
- Enrollment
- 59
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of BordeauxLead sponsor
- Fondation ARCCollaborator
- National Cancer Institute, FranceCollaborator
- University of BordeauxOverall official - principal investigator
- NovartisCollaborator
- University of BordeauxOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.